-+ 0.00%
-+ 0.00%
-+ 0.00%

Revvity Q3 net income rises 34% to $62.3 million; Q3 revenue climbs to $728.9 million

PUBT·11/03/2026 11:02:13
Listen to the news
Revvity Q3 net income rises 34% to $62.3 million; Q3 revenue climbs to $728.9 million
  • Revvity’s third-quarter 2026 GAAP earnings from continuing operations rose 37% year-over-year to $0.56 per share, while revenue increased to $728.9 million.
  • Quarterly operating cash flow from continuing operations climbed 20% year-over-year to $166.7 million.
  • The planned divestiture of its China Immunodiagnostics business is expected to close by the end of 2027, subject to regulatory approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revvity Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261103215457) on November 03, 2026, and is solely responsible for the information contained therein.